Search | La Lingua Nostra

added article Other

2025-08-26 13:34:19 -

End-User Analysis: Biopharma, CROs, Academic & Research Institutions

The U.S. phosphoramidite market, valued at USD 393.05 million in 2024, is anticipated to expand at a CAGR of 7.9% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, end-user applications, and technological platforms. Phosphoramidites are categorized by nucleoside base (adenine, cytosine, guanine, thymine, uracil), modification...

0 Comments 0 Shares 23 Views 0 Reviews